Literature DB >> 25829268

HDAC inhibitors still need a home run, despite recent approval.

Malini Guha.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25829268     DOI： 10.1038/nrd4583

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  36 in total

1.  The Roadmap Epigenomics Project opens new drug development avenues.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2015-04       Impact factor: 84.694

Review 2.  Drugging the pain epigenome.

Authors:  Ellen Niederberger; Eduard Resch; Michael J Parnham; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2017-05-26       Impact factor: 42.937

Review 3.  Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.

Authors:  Thomas Dörner; Peter E Lipsky
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

Review 4.  Fetal haemoglobin induction in sickle cell disease.

Authors:  Alireza Paikari; Vivien A Sheehan
Journal:  Br J Haematol       Date:  2017-11-16       Impact factor: 6.998

5.  Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells.

Authors:  Hui Hui; Xiaoxiao Zhang; Hui Li; Xiao Liu; Le Shen; Yu Zhu; Jingyan Xu; Qinglong Guo; Na Lu
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-16       Impact factor: 4.553

Review 6.  Histone Deacetylase Inhibitors: A Prospect in Drug Discovery.

Authors:  Rakesh Yadav; Pooja Mishra; Divya Yadav
Journal:  Turk J Pharm Sci       Date:  2018-12-31

Review 7.  HDACs and HDAC Inhibitors in Cancer Development and Therapy.

Authors:  Yixuan Li; Edward Seto
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 8.  The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma.

Authors:  Simin Kiany; Douglas Harrison; Nancy Gordon
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 9.  Targeting epigenetic regulations in cancer.

Authors:  Bo Ning; Wenyuan Li; Wei Zhao; Rongfu Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-10-26       Impact factor: 3.848

10.  A structure-activity relationship of non-peptide macrocyclic histone deacetylase inhibitors and their anti-proliferative and anti-inflammatory activities.

Authors:  Subhasish Tapadar; Shaghayegh Fathi; Idris Raji; Wilson Omesiete; James R Kornacki; Sandra C Mwakwari; Masanori Miyata; Kazunori Mitsutake; Jian-Dong Li; Milan Mrksich; Adegboyega K Oyelere
Journal:  Bioorg Med Chem       Date:  2015-11-02       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.